gasticXelox

Description

Data from a Phase II clinical trial of Xeloda and exaliplatin given before surgery to advanced gastric cancer patients with para-aortic lymph node metastasis.

Usage

data("gastricXelox")

Format

A data frame with 48 observations on the following 2 variables.

timeWeeks

survival time in weeks

delta

1 for death, 0 for censored

Details

The data were extracted from the Kaplan-Meier survival plot.

References

Wang Y, Yu Y-Y, Li W, Feng Y, Hou J, Ji Y, Sun Y-H, Shen K-T, Shen Z-B, Qin X-Y, and Liu T-S. (2014) A phase II trial of xeloda and oxaliplatin (XELOX) neo-adjuvant chemotherapy followed by surgery for advanced gastric cancer patients with para-aortic lymph node metastasis. Cancer Chemotherapy and Pharmacology 73(6), 1155-1161.))

Examples

data(gastricXelox)